AI-powered drug discovery: faster hits, better PK, lower costs

• In: AI as a cost-effectiveness accelerator in drug research and development  on Tuesday, 2 September 2025, 14:30-16:00
• At: Copenhagen (Denmark) (2025)
• Type: Presentation
• By: MAILHOT , Olivier
• Abstract:

  Drug discovery differs fundamentally from domains where artificial intelligence (AI) has excelled: experimental data are sparse and biased, while the small-molecule search space is vastly undersampled. In this keynote, Dr Olivier Mailhot reviews the current state of AI in drug discovery, distinguishing durable capabilities from aspirational..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login